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ORIGINAL RESEARCH

Isolated Short Femur Length on
Second-Trimester Sonography
A Marker for Fetal Growth Restriction and Other Adverse
Perinatal Outcomes
Katherine R. Goetzinger, MD, MSCI, Alison G. Cahill, MD, MSCI, George A. Macones, MD, MSCE,
Anthony O. Odibo, MD, MSCE
Objectives—To estimate the association between isolated second-trimester short femur
length and fetal growth restriction as well as other adverse perinatal outcomes.
Methods—We conducted a retrospective cohort study of patients with singleton gestations presenting for sonography between 16 and 24 weeks’ gestation from 1990 to
2009. Cases of aneuploidy, skeletal dysplasia, and major anomalies were excluded. Short
femur length was defined as length below the 10th percentile for gestational age and
was considered isolated when both the estimated fetal weight and abdominal circumference were above the 10th percentile for gestational age. Isolated short femur length
below the 5th percentile was also evaluated. The primary outcome was fetal growth
restriction, defined as birth weight below the 10th percentile. Secondary outcomes
included preeclampsia and preterm birth before 37 and 34 weeks. Univariable and multivariable logistic regression analyses were used to estimate the risk of these outcomes
in fetuses with isolated short femur length.
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Results—Of 73,884 patients, 569 (0.8%) had a fetus with a femur length below the 10th
percentile, of which 268 (47.1%) were isolated; 210 patients (0.3%) had a fetus with a
femur length below the 5th percentile, of which 34 (16.2%) were isolated. Isolated short
femur lengths below the 10th and 5th percentiles were associated with an increased risk of
fetal growth restriction (<10th: adjusted odds ratio [aOR], 3.4; 95% confidence interval
[CI], 2.4–4.6; <5th: aOR, 4.6; 95% CI, 2.0–10.7) and also with an increased risk of
preterm birth before 37 and 34 weeks. There was no significant association between
isolated short femur length and preeclampsia.
Conclusions—Isolated short femur length on second-trimester sonography is associated with a greater than 3-fold increased risk of fetal growth restriction and an increased
risk of preterm birth. Serial growth assessment may be warranted in these cases.
Key Words—fetal growth restriction; preeclampsia; preterm birth; short femur length

G

iven that fetal biometric measurement is a standard component of the second-trimester anatomic survey, identification
of a short femur length on second-trimester sonography is
not an atypical finding. Although it could represent a normal variant,
a short femur length also may indicate inaccurate pregnancy dating
or could be a marker for aneuploidy, congenital malformations,
skeletal dysplasia, or early-onset fetal growth restriction.1–4 In the
absence of these conditions, there are limited data available to guide
patient counseling regarding the implication of an isolated short
femur length found at the time of the anatomic survey.
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It has been suggested that an isolated short femur
length may be an early marker of placental dysfunction as
highly oxygenated fetal blood is preferentially shunted
toward vital organs such as the heart and lungs at the expense
of the extremities.5 In addition, the abnormal placenta may
secrete altered levels of growth factors, which are involved
in normal fetal skeletal development.6 Prior studies have
suggested an association between second-trimester short
femur length and the subsequent development of fetal
growth restriction; however, these studies have been mostly
limited to case series and small observational studies.5,7–9
Furthermore, most of these studies have not evaluated the
association between short femur length and other disorders of placental dysfunction such as preeclampsia and
preterm birth. The objective of this study was to estimate
the association between isolated short femur length on
second-trimester sonography and the subsequent development of fetal growth restriction and other adverse perinatal outcomes using a large sonography and genetics database.

Materials and Methods
We conducted a retrospective cohort study of all consecutive
singleton gestations between 16 and 24 weeks presenting to
Washington University Medical Center between 1990 and
2009. Approval from the Institutional Review Board was
obtained. Maternal demographic information, obstetric
history, maternal medical comorbidities, sonographic findings, pregnancy complications, and neonatal outcomes were
extracted from our sonography and genetics database. This
database was created in 1990 and has been maintained by
dedicated nurse outcome coordinators. All pregnancy and
sonographic data are entered prospectively at the time of the
sonographic examination for patients seen at our institution. Neonatal outcome information is obtained through
review of electronic medical records, questionnaires, and
telephone contact with the patient or referring provider if
necessary. All sonographic examinations were performed by
registered diagnostic medical sonographers certified in
obstetrics, and all examinations were interpreted by maternal-fetal medicine specialists. All pregnancies were dated by
the last menstrual period if consistent with a prior firsttrimester sonographic examination (±7 days) or by crownrump length measurement if it was not consistent with
menstrual dating. For patients who did not have a firsttrimester sonographic examination, menstrual dating was
used if it was consistent (±14 days) with second-trimester
biometric measurements. Cases of aneuploidy, skeletal
dysplasia, and other major congenital malformations, diagnosed either prenatally or postnatally, were excluded.
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Our primary exposures included isolated short femur
length below the 10th and 5th percentiles for gestational
age at the time of the anatomic survey. Femur length was
measured according to standards from the “AIUM Practice
Guideline for the Performance of Obstetric Ultrasound
Examinations.”10 Only the femoral diaphysis length was
included in the measurement, with the beam of insonation
perpendicular to the femoral shaft. This measurement
technique remained consistent throughout the study
period. A short femur was considered isolated when both
the abdominal circumference and estimated fetal weight
measured above the 10th percentile for gestational age.
All gestational age–specific biometric values were determined by standards derived by Hadlock et al.11 Management of the isolated short femur length was left to the
discretion of the patient’s provider.
Our primary outcome of interest was fetal growth
restriction, defined as birth weight below the 10th percentile for gestational age. Secondary outcomes included
preeclampsia, intrauterine fetal death, and preterm birth
before 37 and 34 weeks’ gestation. Preeclampsia was
defined as blood pressure of 140 mm Hg or higher (systolic), 90 mm Hg or higher (diastolic), or both on 2 or
more occasions with proteinuria of 300 mg or greater in a
24-hour urine specimen occurring after 20 weeks’ gestation
in a woman with previously normal blood pressure. If a 24hour urine sample was not available, proteinuria was diagnosed as 1+ or greater on a urine dipstick.12 Intrauterine
fetal death was defined as fetal death at or after 20 weeks’
gestation.
Baseline maternal characteristics as well as the incidence of the primary and secondary outcomes were compared between patients with an isolated short femur length
below the 10th or 5th percentile and patients with a normal
femur length. Student t tests were used to compare continuous variables, and χ2 and Fisher exact tests were used to
compare categorical variables, as appropriate. Univariable
analysis was then used to estimate the relative risk of the
primary and secondary outcomes. Multivariable logistic
regression analysis was used to obtain adjusted odds ratios
and their 95% confidence intervals, accounting for potential
confounders identified both historically and as significant
in the univariable analysis. Logistic regression models were
produced using a backward stepwise elimination method.
Analyses stratified by the presence and absence of fetal
growth restriction were then performed to further refine
risk estimates for our secondary outcomes. P < .05 was
considered statistically significant. All statistical analyses
were performed using STATA 10 Special Edition software
(StataCorp, College Station, TX).
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Results
Our study cohort consisted of 76,453 patients. After patients
with aneuploidy, skeletal dysplasia, major congenital
anomalies, and incomplete pregnancy outcome data were
excluded, 73,884 patients remained for analysis. A total of
569 patients (0.8%) had a short femur length measuring
below the 10th percentile, of which 268 (47.1%) were
isolated; 210 patients (0.3%) had a short femur length
measuring below the 5th percentile, of which 34 (16.2%)
were isolated. There were 5259 cases of fetal growth restriction in the study cohort, for an overall incidence of 7.1%.
The most common indication for sonography was a routine
anatomic survey (48.3%), followed by advanced maternal
age (21.5%), abnormal serum screen results (8.8%), history of a child with a congenital anomaly (2.9%), suspected
fetal anomalies (2.6%), and history of teratogen exposure
(1.4%). The remaining 14.5% of sonographic examinations were performed for a variety of other less common
indications.
On average, patients with a normal femur length at or
above 10th percentile were similar to patients with an isolated short femur length below the 10th percentile with
regard to maternal age, gravidity, parity, and baseline incidence of chronic hypertension and pregestational diabetes.
However, patients with an isolated short femur length
below the 10th percentile were more likely to be white and
were more likely to report a history of tobacco use. Patients
with an isolated short femur length below the 10th percentile
were also more likely to have a diagnosis of this finding at an
earlier gestational age and more likely to be delivered at an

earlier gestational age (Table 1). The incidence rates of
isolated short femur length below the 10th percentile were
0.43% from 1990 to 1999 and 0.31% from 2000 to 2009.
The incidence rates of isolated short femur length below
the 5th percentile were 0.05% from 1990 to 1999 and
0.04% from 2000 to 2009.
Patients with an isolated short femur length below the
10th percentile were at least 3 times more likely to have
fetal growth restriction later in pregnancy compared to
patients with a normal femur length after controlling for
chronic hypertension, African American race, pregestational diabetes, and tobacco use (Table 2). Patients with an
isolated short femur length below the 10th percentile were
also more likely to have preterm delivery before 37 and 34
weeks (Table 2) after controlling for chronic hypertension,
African American race, and pregestational diabetes. There
was no statistically significant increased risk of preeclampsia in patients with an isolated short femur length below
the 10th percentile compared to patients with a normal
femur length (Table 2).
Given the association between fetal growth restriction
and indicated preterm birth, a stratified analysis based on
the presence or absence of fetal growth restriction was performed to further refine the observed association between
isolated short femur length and preterm birth. In patients
with fetal growth restriction, there remained a statistically
significant association between isolated short femur length
below the 10th percentile and both preterm birth before
37 and 34 weeks. In patients without fetal growth restriction,
there still remained a significant association between isolated short femur length below the 10th percentile and

Table 1. Maternal Demographics and Pregnancy Characteristics Comparing Patients With an Isolated Short Femur Length Below the 10th
Percentile to Those With a Femur Length at or Above the 10th Percentile
Characteristic
Maternal age, y
Gestational age at sonography, wk
Gravidity
Parity
Maternal race, %
White
African American
Hispanic
Asian
Other
Tobacco use, %
History of chronic hypertension, %
History of pregestational diabetes, %
Gestational age at delivery, wk

Isolated FL <10th
(n = 268)

FL ≥10th
(n = 73,345)

P

30.5 ± 6.2
18.5 ± 1.6
2.6 ± 1.6
1.0 ± 1.3

29.8 ± 6.4
19.2 ± 1.7
2.7 ± 1.6
1.0 ± 1.2

.07
<.001
.54
.96

75.3
9.1
1.1
1.1
13.4
19.4
2.2
3.4
36.6 ± 6.7

59.2
25.5
1.1
0.9
13.3
11.7
2.5
1.8
38.5 ± 3.7

<.001

<.001
.81
.06
<.001

Values are mean ± SD where applicable. FL indicates femur length.
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preterm birth before 34 weeks; however, there was no
longer an association observed between isolated short
femur length below the 10th percentile and preterm birth
before 37 weeks (Table 3). In the absence of fetal growth
restriction, it is still possible that patients with preterm birth
before 34 weeks represent a more severe end of the spectrum
of placental dysfunction compared to patients with preterm
birth before 37 weeks and therefore manifest signs of early
placental dysfunction such as isolated short femur length.
The findings from this stratified analysis suggest that the
association between isolated short femur length below the
10th percentile and preterm birth before 34 weeks is independent of fetal growth restriction.
Similar findings were observed for isolated short
femur length below the 5th percentile, which was associated with a significantly increased risk of fetal growth
restriction and preterm delivery before 37 and 34 weeks.
For fetal growth restriction, the magnitude of risk was overall similar for isolated short femur length below the 10th and

5th percentiles; however, for preterm birth, the magnitude of
risk was significantly higher in the setting of isolated short
femur length below the 5th percentile compared to isolated short femur length below the 10th percentile. Again,
there was no significant association observed between
isolated short femur length below the 5th percentile and
preeclampsia (Table 4). Given the relatively small number of patients with an isolated short femur length below
the 5th percentile, a stratified analysis based on fetal growth
restriction could not reliably be performed.
There was a higher incidence of intrauterine death in
fetuses with an isolated short femur length below the 10th
percentile (3.36% versus 0.64%; P < .001) and an isolated
short femur length below the 5th percentile (8.82% versus
0.69%) compared to fetuses with a normal femur length.
Of these intrauterine fetal death cases, 5 of 9 with an isolated
short femur length below the 10th percentile and 2 of 3
with an isolated short femur length below the 5th percentile were also growth restricted.

Table 2. Unadjusted and Adjusted Risk Estimates for Adverse Outcomes in Fetuses With an Isolated Short Femur Length Below the 10th Percentile for Gestational Age
Outcome
FGR, %
(n = 5,259)
Preeclampsia, %
(n = 5,166)
PTB <37 wk, %
(n = 7,421)
PTB <34 wk, %
(n = 1,948)

Isolated FL <10th
(n = 268)
21.5

FL ≥10th
(n = 73,345)
8.3

8.4

8.0

17.7

11.4

10.3

2.9

Unadjusted RR
(95% CI)
2.6
(2.0–3.3)
1.0
(0.7–1.6)
1.5
(1.2–2.0)
3.5
(2.4–5.2)

aOR
(95% CI)

P

3.4a

<.001

(2.4–4.6)
ND

.85

1.8b
(1.3–2.5)
4.6b
(3.0–7.0)

.001
<.001

aOR indicates adjusted odds ratio; CI, confidence interval; FGR, fetal growth restriction; FL, femur length; ND, not determined; PTB, preterm
birth; and RR, relative risk.
aAdjusted for chronic hypertension, African American race, diabetes, and tobacco use.
bAdjusted for chronic hypertension, African American race, and diabetes
Table 3. Unadjusted and Adjusted Risk Estimates for Preterm Birth Stratified by Fetal Growth Restriction
Outcome
FGR (n = 5,259)
PTB <37 wk, %
(n = 1,166)
PTB <34 wk,%
(n = 530)
No FGR (n = 68,354)
PTB <37 wk, %
(n = 6,255)
PTB <34 wk, %
(n = 1,948)

Isolated FL <10th
(n = 268)

FL ≥10th
(n = 73,345)

40.8

21.8

28.6

9.5

11.2

10.5

5.6

2.4

Unadjusted RR
(95% CI)

aOR
(95% CI)

P

1.9
(1.3–2.6)
3.0
(1.9–4.7)

2.9a
(1.6–5.2)
4.7a
(2.5–8.8)

1.1
(0.7–1.6)
2.4
(1.3–4.3)

ND

.750

2.8a
(1.4–5.3)

.004

.001
<.001

Abbreviations are as in Table 2.
aAdjusted for chronic hypertension, African American race, and diabetes.
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Discussion
Findings from our large cohort confirm the association
between isolated short femur length on second-trimester
sonography and fetal growth restriction and also suggest a
novel association between isolated short femur length and
preterm birth. This association with early preterm birth
before 34 weeks appears to be independent of fetal growth
restriction and also increases in magnitude as the short femur
length measurement decreases. Our study also showed a
higher incidence of intrauterine fetal death in patients with
an isolated short femur length; however, given the absolute
small number of cases, we were unable to determine whether
this finding was independent of fetal growth restriction.
In 2004, Todros et al7 followed 86 pregnancies with a short
femur length below the 10th percentile diagnosed at the time
of the anatomic survey and noted that 21% of these patients
subsequently had fetal growth restriction. On average, fetal
growth restriction was diagnosed approximately 9 weeks
after the initial finding of a short femur length.7 In 2008,
Weisz et al5 used a stricter definition of isolated short femur
length below the 5th percentile and similarly showed an
increased risk of fetal growth restriction (odds ratio, 3.0;
95% confidence interval, 1.5–5.9); however, no difference
in the incidence of preterm birth was observed in that study
when comparing fetuses with an isolated short femur length
to those with a normal femur length. Prior studies evaluating
the association between isolated short femur length and
preeclampsia have been conflicting. In a small retrospective
observational study, Zalel et al6 observed that 7 of 9 patients
with an isolated short femur length had pregnancy-induced
hypertension. Todros et al7 observed a 19% incidence of
preeclampsia in 46 structurally normal fetuses with an isolated short femur length; however, all of those patients also

had a diagnosis of fetal growth restriction. Consistent with
our findings, more recent larger observational cohort
studies have shown no statistically significant increased
risk of hypertensive complications of pregnancy in patients
with an isolated short femur length.5,9
One potential mechanism for our findings is that
abnormal placentation leads to altered secretion of fibroblast growth factor 2, which is normally secreted by the
human placenta and plays a role in skeletal development.
Altered secretion of this growth factor could result in inhibition of long bone growth in the fetus.6,13 Another potential
mechanism involves the fetal adaptive response to chronic
hypoxia in which highly oxygenated blood is shunted
toward vital fetal organs such as the brain and heart at the
expense of the extremities. Short femur length may represent the earliest sign of this adaptive response observed in
cases of placental insufficiency.5 Although preeclampsia is
a recognized syndrome of placental dysfunction, it is possible that preeclampsia results in altered secretion of a distinctive profile of placental factors that do not include
fibroblast growth factor 2, which could explain the lack of
association found between isolated short femur length and
preeclampsia in our study. The biological mechanism
underlying the association between short femur length and
preterm birth is less clear; however, abnormal placentation
has more recently been shown to play a role in the pathogenesis of preterm birth as well. As in the case of fetal growth
restriction, short femur length may be an early sign of
abnormal placentation and placental insufficiency, thereby
providing biological plausibility to the association observed
between short femur length and early preterm birth.14,15
Findings from this study certainly have potential
clinical implications for the management of these pregnancies. Given the association between isolated short femur

Table 4. Unadjusted and Adjusted Risk Estimates for Adverse Outcomes in Fetuses With an Isolated Short Femur Length Below the
5th Percentile for Gestational Age
Outcome
FGR, %
(n = 5,207)
Preeclampsia, %
(n = 5,155)
PTB <37 wk, %
(n = 7,391)
PTB <34 wk, %
(n = 1,924)

Isolated FL <5th
(n = 34)
29.6

FL ≥5th
(n = 73,674)
8.4

15.1

8.1

34.6

11.4

30.8

3.0

Unadjusted RR
(95% CI)
3.5
(2.0–6.3)
1.9
(0.8–4.2)
3.0
(1.8–5.1)
10.4
(5.8–18.5)

aOR
(95% CI)

P

4.6a

<.001

(2.0–10.7)
ND

.18

4.3b
(1.9–9.8)
17.8b
(7.7-41.6)

.002
<.001

Abbreviations are as in Table 2.
aAdjusted for chronic hypertension, African American race, diabetes, and tobacco use.
bAdjusted for chronic hypertension, African American race, and diabetes.
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length and fetal growth restriction, repeated sonography for
fetal growth during the third trimester may be warranted.
Because our study was not designed to evaluate the timing
of fetal growth restriction development in these fetuses,
it is not possible to draw a conclusion regarding the ideal
gestational age at which to perform a single repeated growth
assessment or whether serial sonographic evaluations
throughout the third trimester are necessary. For the
association observed between isolated short femur length
and preterm birth, heightened clinical awareness of signs
and symptoms of preterm labor certainly is warranted.
Future studies regarding the performance of other preterm
birth screening and prevention strategies in this particular
group of patients may provide more information on the
appropriate clinical management.
To our knowledge, this is the largest study to date evaluating the association between isolated short femur length
and adverse perinatal outcomes. Given the large sample
size derived from our robust sonography and genetics database, we were able to evaluate the definitions of both short
femur length below the 10th percentile and short femur
length below the 5th percentile as well as provide quantitative estimates of risk, adjusting for potential confounding factors. In addition, we were able to reliably evaluate
only cases of isolated short femur length by excluding all
patients with aneuploidy, congenital anomalies, skeletal
dysplasias, and early-onset fetal growth restriction.
Limitations of our study include its retrospective
design and its inherent potential for misclassification bias;
however, our perinatal database is maintained by dedicated
nurse outcome coordinators, and the follow-up system in
our center has been well validated in previous studies,
making the possibility for misclassification minimal.16,17
This study took place over a 19-year period, and sonographic examinations were performed by multiple sonographers using a variety of different ultrasound machines.
Although this factor could be viewed as a limitation, we
believe it also contributes to the generalizability of our
findings. When dividing our cohort in half, we observed a
comparable number of cases of isolated short femur length
diagnosed in both study periods, indicating that this diagnosis has remained stable over time despite advances in
sonography practice and technology. Despite our large
cohort, the finding of an isolated short femur length was
still relatively rare, thereby limiting some aspects of our
analysis. The small number of cases of isolated short femur
length below the 5th percentile precluded stratified analyses and also resulted in risk estimates with wide confidence
intervals. In addition, we were unable to completely separate spontaneous and indicated preterm birth using our

1940

perinatal database; however, we were able to stratify on the
basis of fetal growth restriction, a common indication for
preterm delivery. The combination of spontaneous and
indicated preterm birth into a single category certainly
creates a potentially heterogeneous outcome with contributions from both known and unknown confounders;
however, more recent data suggest that spontaneous and
indicated preterm birth may have similar underlying
pathophysiologic characteristics, therefore making this distinction less essential.18 Finally, although our population
did include multiple ethnic groups, our study cohort was
still primarily composed of white patients. It has been suggested that race-specific definitions of short femur length
may improve its discriminatory value in the setting of
Down syndrome screening; however, that association has
not been shown in our patient population.19
In conclusion, the finding of isolated short femur
length below the 10th or 5th percentile at the time of secondtrimester sonography is associated with a greater than 3fold increased risk of the subsequent development of fetal
growth restriction as well as an increased risk of preterm
birth before 34 and 37 weeks. Isolated short femur length
may be the first identifiable biometric marker for placental
insufficiency. Repeated sonography for fetal growth as well
as heightened awareness of signs and symptoms of preterm
labor should be considered in cases of isolated short femur
length identified at the time of the anatomic survey.
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